Erlotinib in gliomas: should selection be based on EGFR and Akt analyses?
- PMID: 15956643
- DOI: 10.1093/jnci/dji169
Erlotinib in gliomas: should selection be based on EGFR and Akt analyses?
Comment on
-
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.J Natl Cancer Inst. 2005 Jun 15;97(12):880-7. doi: 10.1093/jnci/dji161. J Natl Cancer Inst. 2005. PMID: 15956649 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous